Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Medicine, Multiple sclerosis, Internal medicine, Natalizumab, Cohort, and Expanded Disability Status Scale.
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression
Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple Sclerosis
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
Early clinical markers of aggressive multiple sclerosis
Delay from treatment start to full effect of immunotherapies for multiple sclerosis
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy
Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response
Defining secondary progressive multiple sclerosis
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study
Contribution of different relapse phenotypes to disability in multiple sclerosis
Defining reliable disability outcomes in multiple sclerosis
Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
Teriflunomide added to interferon-β in relapsing multiple sclerosis
Increasing age at disability milestones among MS patients in the MSBase Registry